Pitango led a $108m Series C round in Patient21.

Pitango, a venture capital company, led a $108m Series C round in Patient21, a healthtech company, with participation from Bertelsmann Investments, Artian, Target Global, Piton Capital, PICO Venture Partners, Mario Kohle and Maria Raga. “Dentistry inherently requires in-person consultations for comprehensive diagnosis and treatment. The nature of dentistry involves visually inspecting oral health, utilizing diagnostic tools like x-rays and addressing emergencies promptly. These aspects are best served through onsite consultations to ensure the highest standards of care," Chris Muhr, Patient21 Co-Founder and CEO.